Assignee
COCRYSTAL PHARMA INC
US·14 granted patents·5 pending applications·86 citations·filing 2013–2022
Top patents by PatentIndex Score
19 records- 0196US9173893B2Purine nucleoside monophosphate prodrugs for treatment of cancer and viral infectionsCOCRYSTAL PHARMA INC·Filed 2013·Granted Nov 3, 2015·52 cites·16 claims
- 0291US9181227B2Potent and selective inhibitors of hepatitis C virusCOCRYSTAL PHARMA INC·Filed 2014·Granted Nov 10, 2015·8 cites·5 claims
- 0389US9809616B2Pyrimidine nucleosides and their monophosphate prodrugs for the treatment of viral infections and cancerCOCRYSTAL PHARMA INC·Filed 2013·Granted Nov 7, 2017·15 cites·11 claims
- 0487US11014941B2Pyrrolopyrimidine derivatives useful as inhibitors of influenza virus replicationCOCRYSTAL PHARMA INC·Filed 2018·Granted May 25, 2021·4 cites·20 claims
- 0583US10947210B2Inhibitors of Hepatitis C virus polymeraseCOCRYSTAL PHARMA INC·Filed 2019·Granted Mar 16, 2021·2 cites·8 claims
- 0683US10464914B2Inhibitors of hepatitis C virus polymeraseCOCRYSTAL PHARMA INC·Filed 2016·Granted Nov 5, 2019·5 cites·21 claims
- 0760US2024398757A1Inhibitors for coronavirusesCOCRYSTAL PHARMA INC·Filed 2022·Application pending·0 cites
- 0856US2023159453A1Inhibitors of norovirus and coronavirus replicationCOCRYSTAL PHARMA INC·Filed 2021·Application pending·0 cites
- 0954US12233066B2Combinations of inhibitors of influenza virus replicationCOCRYSTAL PHARMA INC·Filed 2019·Granted Feb 25, 2025·0 cites·20 claims
- 1052US12357631B2Pyrrolo[2,3-B]pyridin derivatives as inhibitors of influenza virus replicationCOCRYSTAL PHARMA INC·Filed 2019·Granted Jul 15, 2025·0 cites·19 claims
- 1151US11752166B2Combination therapy for treatment of HCVCOCRYSTAL PHARMA INC·Filed 2019·Granted Sep 12, 2023·0 cites·19 claims
- 1251US2023151034A1Peptidomimetic n5-methyl-n2-(nonanoyl-l-leucyl)-l-glutaminate derivatives, triazaspiro[4.14]nonadecane derivatives and similar compounds as inhibitors of norovirus and coronavirus replicationCOCRYSTAL PHARMA INC·Filed 2021·Application pending·0 cites
- 1350US12156876B2Formulations of influenza therapeuticsCOCRYSTAL PHARMA INC·Filed 2019·Granted Dec 3, 2024·0 cites·19 claims
- 1447US12565488B2Inhibitors of influenza virus replicationCOCRYSTAL PHARMA INC·Filed 2019·Granted Mar 3, 2026·0 cites·24 claims
- 1546US12037333B2Pyridopyrazine and pyridotriazine inhibitors of influenza virus replicationCOCRYSTAL PHARMA INC·Filed 2019·Granted Jul 16, 2024·0 cites·22 claims
- 1641US9926295B2Potent and selective inhibitors of hepatitis C virusCOCRYSTAL PHARMA INC·Filed 2015·Granted Mar 27, 2018·0 cites·13 claims
- 1739US2017037078A12' -disubstituted nucleoside analogs for treatment of the flaviviridae family of viruses and cancerCOCRYSTAL PHARMA INC·Filed 2015·Application pending·0 cites
- 1837US2017334941A12',2'-dihalo nucleoside analogs for treatment of the flaviviridae family of viruses and cancerCOCRYSTAL PHARMA INC·Filed 2015·Application pending·0 cites
- 1934US10011629B2Nucleoside analogs for treatment of the flaviviridae family of viruses and cancerCOCRYSTAL PHARMA INC·Filed 2016·Granted Jul 3, 2018·0 cites·17 claims
Join the waitlist — get patent alerts
Get an alert when COCRYSTAL PHARMA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →